HomeCompareDACHF vs MAIN

DACHF vs MAIN: Dividend Comparison 2026

DACHF yields 4.16% · MAIN yields 6.91%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MAIN wins by $31.19M in total portfolio value
10 years
DACHF
DACHF
● Live price
4.16%
Share price
$8.44
Annual div
$0.35
5Y div CAGR
71.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11.70M
Annual income
$9,653,176.75
Full DACHF calculator →
MAIN
Main Street Capital Corporation
● Live price
6.91%
Share price
$52.96
Annual div
$3.66
5Y div CAGR
72.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.89M
Annual income
$35,818,348.00
Full MAIN calculator →

Portfolio growth — DACHF vs MAIN

📍 MAIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDACHFMAIN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DACHF + MAIN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DACHF pays
MAIN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DACHF
Annual income on $10K today (after 15% tax)
$353.96/yr
After 10yr DRIP, annual income (after tax)
$8,205,200.24/yr
MAIN
Annual income on $10K today (after 15% tax)
$587.42/yr
After 10yr DRIP, annual income (after tax)
$30,445,595.80/yr
At 15% tax rate, MAIN beats the other by $22,240,395.56/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DACHF + MAIN for your $10,000?

DACHF: 50%MAIN: 50%
100% MAIN50/50100% DACHF
Portfolio after 10yr
$27.29M
Annual income
$22,735,762.37/yr
Blended yield
83.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MAIN right now

DACHF
No analyst data
Altman Z
2.0
Piotroski
5/9
MAIN
Analyst Ratings
2
Buy
11
Hold
Consensus: Hold
Price Target
$65.25
+23.2% upside vs current
Range: $60.00 — $70.00
Altman Z
1.7
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DACHF buys
0
MAIN buys
0
No recent congressional trades found for DACHF or MAIN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDACHFMAIN
Forward yield4.16%6.91%
Annual dividend / share$0.35$3.66
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR71.7%72.7%
Portfolio after 10y$11.70M$42.89M
Annual income after 10y$9,653,176.75$35,818,348.00
Total dividends collected$11.50M$41.85M
Payment frequencyquarterlymonthly
SectorStockBDC

Year-by-year: DACHF vs MAIN ($10,000, DRIP)

YearDACHF PortfolioDACHF Income/yrMAIN PortfolioMAIN Income/yrGap
1← crossover$11,415$715.00$12,434$1,193.51$1.0KMAIN
2$13,524$1,309.68$16,255$2,280.05$2.7KMAIN
3$16,960$2,489.85$22,851$4,580.08$5.9KMAIN
4$23,158$5,010.66$35,577$9,892.59$12.4KMAIN
5$35,758$10,978.76$63,653$23,664.70$27.9KMAIN
6$65,464$27,202.50$136,601$65,054.52$71.1KMAIN
7$149,960$79,913.86$368,044$214,504.02$218.1KMAIN
8$454,211$293,754.32$1,301,668$887,987.40$847.5KMAIN
9$1,913,762$1,427,755.53$6,288,483$4,825,407.47$4.37MMAIN
10$11,700,902$9,653,176.75$42,886,603$35,818,348.00$31.19MMAIN

DACHF vs MAIN: Complete Analysis 2026

DACHFStock

Daicel Corporation engages in the medical/healthcare, smart, safety, materials, engineering plastics, and other businesses in Japan, China, and internationally. The company offers 1,3-Butylene glycol and polyglycerin for cosmetics; chiral and achiral columns/stationary phases, analytical tools, analytical/purification/synthesis/formulation services, chiral and bio reagents, analytical standards, and DNA and RNA-based probes; triacetylcellulose, high performance film, solvent for electronic materials, polymer for resist, semiconductor process cleaning agent, optical parts and lens unit, silver nanoparticle ink, and organic semiconductor devices; and inflators, pyro-fuse, and safety device for non-mobility products; and acetic acid and derivatives, cellulose acetate, acetate tow, cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines. It also provides ceramide derived from konjac root, equol derived from soybeans, ß-cryptoxanthin derived from citrus unshiu, and lactobionic acid derived from milk; DiSPERZiSTA, a dispersible filler for dietary supplement tablet; and MOiSTCARM, a make granules easy to swallow. In addition, the company offers engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films; water treatment systems and diffusers, such as UF membrane modules, ultra-fine bubble membrane diffusers, and E mizu showers. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

Full DACHF Calculator →

MAINBDC

Main Street Capital Corporation is a business development company specializes in equity capital to lower middle market companies. The firm specializing in recapitalizations, management buyouts, refinancing, family estate planning, management buyouts, refinancing, industry consolidation, mature, later stage emerging growth. The firm also provides debt capital to middle market companies for acquisitions, management buyouts, growth financings, recapitalizations and refinancing. The firm seeks to partner with entrepreneurs, business owners and management teams and generally provides one stop financing alternatives within its lower middle market portfolio. It prefers to invest in air freight and logistics, auto components, building products, chemicals, commercial services, computers, construction and engineering, consumer finance, consumer services, electronic equipment, energy equipment and services, financial services, health care equipment, health care providers, hotels, restaurants, and leisure, internet software and services, IT Services, machinery, oil, gas and consumable fuels, paper and forest products, professional and industrial services, road and rail, software, specialty retail, telecommunication, consumer discretionary, energy, materials, technology, and transportation. The firm typically invests in lower middle market companies generally with annual revenues between $5 million and $300 million. It prefers to invest in ranging between $2 million and $75 million in equity investment and enterprise value in ranging between $3 million and $20 million. The firm typically prefers to invest in the range of $5 million and $50 million per transaction in debt investment value and in the range of $1 million and $20 million in annual EBITDA. The firm's middle market debt investments are made in businesses that are generally larger in size than its lower middle market portfolio companies. It takes 5 percent minority and up to 50 percent majority equity investments. Main Street Capital Corporation was founded in 2007 and is based in Houston, Texas with an additional office in Chojnów, Poland.

Full MAIN Calculator →
📬

Get this DACHF vs MAIN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DACHF vs SCHDDACHF vs JEPIDACHF vs ODACHF vs KODACHF vs ARCCDACHF vs HTGCDACHF vs GBDCDACHF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.